Jacobson Pharma Corporation Limited (HKG:2633)
1.270
0.00 (0.00%)
At close: Feb 13, 2026
HKG:2633 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 395.06 | 509.05 | 411.94 | 1,036 | 478.65 | 480.35 |
Short-Term Investments | 42.45 | 39.45 | 46.24 | 52.1 | 51.43 | 43.06 |
Cash & Short-Term Investments | 437.52 | 548.49 | 458.17 | 1,089 | 530.08 | 523.41 |
Cash Growth | -22.40% | 19.71% | -57.91% | 105.35% | 1.27% | 5.52% |
Accounts Receivable | 164.46 | 145.09 | 172.83 | 288.23 | 308.94 | 260.99 |
Other Receivables | 17.25 | 11.49 | 15.55 | 12.66 | 24.67 | 20.19 |
Receivables | 181.71 | 156.58 | 188.39 | 300.89 | 333.61 | 281.19 |
Inventory | 347.71 | 332.88 | 317.86 | 368 | 314.56 | 356.18 |
Total Current Assets | 966.93 | 1,038 | 964.42 | 1,757 | 1,178 | 1,161 |
Property, Plant & Equipment | 1,503 | 1,494 | 1,301 | 1,502 | 1,504 | 1,551 |
Long-Term Investments | 395.18 | 449.38 | 481.51 | 569.77 | 471.03 | 519.86 |
Goodwill | - | 183.72 | 183.72 | 450.57 | 444.26 | 444.26 |
Other Intangible Assets | 427.41 | 174.45 | 187.54 | 805.1 | 805.19 | 851.93 |
Long-Term Deferred Tax Assets | 10.66 | 10.23 | 10.85 | 10.23 | 10.16 | 10.26 |
Long-Term Deferred Charges | - | 62.96 | 64.59 | 64.41 | 53.73 | 48.88 |
Other Long-Term Assets | 224.38 | 232.37 | 292.8 | 220.87 | 289.16 | 280.57 |
Total Assets | 3,528 | 3,645 | 3,487 | 5,380 | 4,756 | 4,867 |
Accounts Payable | 43.32 | 41.66 | 51.69 | 80.25 | 50.46 | 38.59 |
Accrued Expenses | 89.42 | 57.58 | 53.66 | 58.32 | 51.59 | 42.05 |
Current Portion of Long-Term Debt | 391.9 | 237.2 | 112.8 | 309.55 | 612.18 | 685.91 |
Current Portion of Leases | 29.76 | 24.01 | 26.87 | 34.82 | 33.97 | 35.94 |
Current Income Taxes Payable | 58.76 | 33.2 | 16.7 | 28.41 | 20.83 | 14.33 |
Current Unearned Revenue | 24.43 | 24.17 | 60.88 | 54.89 | 3.74 | 3.43 |
Other Current Liabilities | 48.66 | 135.33 | 50.24 | 90.21 | 53.62 | 53.65 |
Total Current Liabilities | 686.24 | 553.14 | 372.84 | 656.44 | 826.38 | 873.91 |
Long-Term Debt | 444.5 | 476.5 | 592.2 | 1,234 | 729.47 | 892.21 |
Long-Term Leases | 38.46 | 35.5 | 17.51 | 20.53 | 34.32 | 34.56 |
Long-Term Deferred Tax Liabilities | 99.88 | 102.58 | 107.94 | 212.86 | 207.4 | 206.36 |
Total Liabilities | 1,269 | 1,168 | 1,090 | 2,124 | 1,798 | 2,007 |
Common Stock | 20 | 19.94 | 19.8 | 19.08 | 19.16 | 19.16 |
Additional Paid-In Capital | 1,038 | 1,038 | 1,038 | 999.9 | 999.9 | 999.9 |
Retained Earnings | 1,092 | 1,176 | 1,002 | 1,468 | 1,381 | 1,230 |
Comprehensive Income & Other | 84.42 | 219.57 | 312.19 | 250.09 | 91.22 | 140.6 |
Total Common Equity | 2,234 | 2,453 | 2,372 | 2,737 | 2,491 | 2,390 |
Minority Interest | 24.22 | 24.22 | 24.22 | 519.83 | 466.65 | 470.26 |
Shareholders' Equity | 2,259 | 2,477 | 2,396 | 3,257 | 2,958 | 2,860 |
Total Liabilities & Equity | 3,528 | 3,645 | 3,487 | 5,380 | 4,756 | 4,867 |
Total Debt | 904.62 | 773.21 | 749.38 | 1,599 | 1,410 | 1,649 |
Net Cash (Debt) | -467.11 | -224.72 | -291.21 | -510.54 | -879.86 | -1,125 |
Net Cash Per Share | -0.23 | -0.11 | -0.15 | -0.27 | -0.46 | -0.59 |
Filing Date Shares Outstanding | 2,000 | 1,994 | 1,980 | 1,908 | 1,916 | 1,916 |
Total Common Shares Outstanding | 2,000 | 1,994 | 1,980 | 1,908 | 1,916 | 1,916 |
Working Capital | 280.69 | 484.81 | 591.57 | 1,101 | 351.86 | 286.88 |
Book Value Per Share | 1.12 | 1.23 | 1.20 | 1.43 | 1.30 | 1.25 |
Tangible Book Value | 1,807 | 2,095 | 2,001 | 1,481 | 1,242 | 1,094 |
Tangible Book Value Per Share | 0.90 | 1.05 | 1.01 | 0.78 | 0.65 | 0.57 |
Land | - | 1,214 | 1,152 | 127.43 | 103.06 | 102.34 |
Buildings | - | - | - | 1,130 | 1,078 | 1,058 |
Machinery | - | 937.91 | 908.37 | 1,018 | 1,002 | 973.99 |
Leasehold Improvements | - | 127.22 | 40.63 | 42.25 | 45.58 | 36.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.